Literature DB >> 2884224

gamma-Glutamyl transpeptidase (gamma-GT) and maintenance of thiol pools in tumor cells resistant to alkylating agents.

S Ahmad, L Okine, R Wood, J Aljian, D T Vistica.   

Abstract

Previous studies from this laboratory have established that acquired resistance of murine L1210 leukemia cells to L-phenylalanine mustard (L-PAM) and other alkylating agents is accompanied by a two-to threefold elevation in their glutathione (GSH) concentration (Biochem. Pharm. 31:121). In an attempt to gain insight into the mechanism by which resistant tumor cells maintain their increased GSH content, we have assessed the possible role of gamma-glutamyl transpeptidase (gamma-GT), a membrane bound enzyme involved in GSH metabolism. These results indicate that the enzyme is present in both sensitive and resistant murine L1210 leukemia cells but that the cellular content of gamma-GT is elevated two-to threefold in L-PAM resistant cells as compared to their sensitive counterparts. This elevation in enzymatic activity correlates well with the increased cellular GSH content in resistant cells. The results of a detailed kinetic analysis of gamma-GT activity indicate that there is no difference, between cell types, in the apparent Km of the enzyme for the gamma-glutamyl donor (L-gamma-glutamyl-p-nitroanilide) or the acceptor (glycylglycine). However, the apparent Vmax is increased two-to threefold in L-PAM resistant tumor cells. Investigation into the role of gamma-GT in the extracellular metabolism of GSH indicates that resistant tumor cells metabolize two-fold more GSH than do sensitive cells and that such metabolism results in a similar difference in the intracellular concentration of cysteine. Results of studies with cellular lysates also indicate a role for the enzyme in the supply of cysteine to the glutathione precursor pool of the tumor cell and in the maintenance of elevated GSH concentrations in cells resistant to alkylating agents.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2884224     DOI: 10.1002/jcp.1041310214

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  16 in total

Review 1.  γ-Glutamyltranspeptidases: sequence, structure, biochemical properties, and biotechnological applications.

Authors:  Immacolata Castellano; Antonello Merlino
Journal:  Cell Mol Life Sci       Date:  2012-04-21       Impact factor: 9.261

2.  Antioxidant and glutathione-associated enzymes in Wilms' tumour after chemotherapy.

Authors:  J Gajewska; M Szczypka; T Izbicki; T Klepacka; T Laskowska-Klita
Journal:  J Cancer Res Clin Oncol       Date:  1996       Impact factor: 4.553

Review 3.  The Glutathione Conundrum: Stoichiometric Disconnect between Its Formation and Oxidative Stress.

Authors:  Gunnar Boysen
Journal:  Chem Res Toxicol       Date:  2017-04-26       Impact factor: 3.739

4.  Glutathione and glutathione conjugate efflux from cultured liver cells.

Authors:  M J Meredith
Journal:  Cell Biol Toxicol       Date:  1991-01       Impact factor: 6.691

5.  Differential diagnosis of histogenetically distinct human epithelial renal tumours with a monoclonal antibody against gamma-glutamyltransferase.

Authors:  P Fischer; S Störkel; W Haase; J E Scherberich
Journal:  Cancer Immunol Immunother       Date:  1991       Impact factor: 6.968

6.  Immunoscintigraphic localization of renal tumours in an extracorporeal perfusion model with a monoclonal antibody against gamma-glutamyltransferase.

Authors:  P Fischer; R P Baum; M Tauber; W Boeckmann; S Weier; J E Scherberich
Journal:  Cancer Immunol Immunother       Date:  1992       Impact factor: 6.968

Review 7.  Chemotherapeutic drug resistance in the management of head and neck cancer.

Authors:  H Bier
Journal:  Eur Arch Otorhinolaryngol       Date:  1993       Impact factor: 2.503

8.  Amplification and increased expression of alpha class glutathione S-transferase-encoding genes associated with resistance to nitrogen mustards.

Authors:  A D Lewis; I D Hickson; C N Robson; A L Harris; J D Hayes; S A Griffiths; M M Manson; A E Hall; J E Moss; C R Wolf
Journal:  Proc Natl Acad Sci U S A       Date:  1988-11       Impact factor: 11.205

9.  Characterization of an established human, malignant, glioblastoma cell line (GBM) and its response to conventional drugs.

Authors:  P Perego; A Boiardi; N Carenini; M De Cesare; E Dolfini; I Magnani; S Martignone; A Silvani; C Soranzo
Journal:  J Cancer Res Clin Oncol       Date:  1994       Impact factor: 4.553

10.  High resistance to cisplatin in human ovarian cancer cell lines is associated with marked increase of glutathione synthesis.

Authors:  A K Godwin; A Meister; P J O'Dwyer; C S Huang; T C Hamilton; M E Anderson
Journal:  Proc Natl Acad Sci U S A       Date:  1992-04-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.